Marini A, Hengge U R
Hautklinik der Heinrich-Heine-Universität, Moorenstrasse 5, 40225 Düsseldorf.
Hautarzt. 2007 Jun;58(6):532-6. doi: 10.1007/s00105-006-1183-y.
A 72-year-old patient with esophageal carcinoma developed a severe hand-foot syndrome during second-line therapy with the oral fluoropyrimidine capecitabine. We also summarize the current knowledge with regard to the hand-foot syndrome and distinguish it from palmoplantar erythrodysesthesia.
一名72岁的食管癌患者在接受口服氟嘧啶卡培他滨进行二线治疗期间出现了严重的手足综合征。我们还总结了目前关于手足综合征的知识,并将其与掌跖红斑感觉异常区分开来。